Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor
Authors:
- Deepa ShettyDSDeepa Shetty
- Ken LeKLKen Le
- Chuong BuiCBChuong Bui
- Robert MansbergRMRobert Mansberg
- Han LohHLHan Loh
- 1 October 2016
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (10) , 804-806
Abstract
Ga-PSMA PET/CT is increasingly used to evaluate recurrent prostatic malignancy due to its high specificity. A 75-year-old man with a previous history of treated prostate cancer 3 years earlier presented with rising prostate-specific antigen (PSA) level and underwent Ga-PSMA PET/CT which demonstrated a PSMA-avid focus in the neck of the pancreas. Triple-phase abdominal CT demonstrated enhancement in the arterial phase and to a lesser extent the venous phase of a soft tissue mass in the neck of the pancreas. Cytological and histopathological examination of the soft tissue mass confirmed a low-grade pancreatic neuroendocrine tumor.Keywords
This publication has 15 references indexed in Scilit:
- In Vivo Visualization of Prostate-Specific Membrane Antigen in Adenoid Cystic Carcinoma of the Salivary GlandClinical Nuclear Medicine, 2016
- Desmoid Tumor Showing Intense Uptake on 68Ga PSMA-HBED-CC PET/CTClinical Nuclear Medicine, 2016
- PSMA Expression in Papillary Thyroid CarcinomaClinical Nuclear Medicine, 2016
- 68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node MetastasesClinical Nuclear Medicine, 2016
- Rectal Carcinoma on 68Ga-PSMA PET/CTClinical Nuclear Medicine, 2016
- 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- PSMA PET in Prostate CancerJournal of Nuclear Medicine, 2015
- Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastasesCancer Cell International, 2014
- PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane AntigenCurrent Topics in Medicinal Chemistry, 2013
- Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasesUrology, 1998